Simplex Trading
BNTX icon

Simplex Trading’s BioNTech BNTX Stock Holding History

Simplex Trading’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.41M Buy
36,700
+20,700
+129% +$1.95M ﹤0.01% 1513
2026
Q1 		$1.42M Sell
16,000
-11,200
-41% -$1.15M ﹤0.01% 2133
2025
Q4 		$2.59M Sell
27,200
-22,300
-45% -$2.25M ﹤0.01% 1772
2025
Q3 		$4.88M Buy
49,500
+12,700
+35% +$1.36M ﹤0.01% 1481
2025
Q2 		$3.92M Sell
36,800
-17,600
-32% -$1.78M ﹤0.01% 1553
2025
Q1 		$4.95M Sell
54,400
-55,000
-50% -$6.16M ﹤0.01% 1312
2024
Q4 		$12.5M Sell
109,400
-31,200
-22% -$3.56M 0.01% 897
2024
Q3 		$16.7M Buy
140,600
+48,100
+52% +$4.42M 0.01% 742
2024
Q2 		$7.43M Sell
92,500
-33,200
-26% -$3.03M ﹤0.01% 1201
2024
Q1 		$11.6M Sell
125,700
-145,300
-54% -$13.9M 0.01% 1037
2023
Q4 		$28.2M Buy
271,000
+200,600
+285% +$20.2M 0.02% 566
2023
Q3 		$7.65M Sell
70,400
-110,800
-61% -$12.3M 0.01% 1066
2023
Q2 		$19.6M Buy
181,200
+165,600
+1,062% +$18.6M 0.02% 586
2023
Q1 		$1.94M Sell
15,600
-44,700
-74% -$6.14M ﹤0.01% 1972
2022
Q4 		$9.06M Buy
60,300
+18,800
+45% +$2.89M 0.01% 894
2022
Q3 		$5.6M Buy
41,500
+9,100
+28% +$1.39M 0.01% 1124
2022
Q2 		$4.83M Sell
32,400
-51,500
-61% -$7.87M 0.01% 1171
2022
Q1 		$14.3M Sell
83,900
-52,900
-39% -$8.89M 0.01% 661
2021
Q4 		$35.3M Buy
136,800
+95,300
+230% +$26.1M 0.04% 346
2021
Q3 		$9.3M Buy
41,500
+2,700
+7% +$858K 0.01% 763
2021
Q2 		$8.69M Buy
38,800
+38,540
+14,823% +$7.27M 0.01% 789
2021
Q1 		$2.84M Sell
260
-189
-42% -$20.1K 0.01% 1269
2020
Q4 		$3.66M Buy
449
+117
+35% +$11.5K ﹤0.01% 1221
2020
Q3 		$2.3M Buy
332
+252
+315% +$18.1K ﹤0.01% 1418
2020
Q2 		$533K Buy
+80
New +$4K ﹤0.01% 2816

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Simplex Trading's BNTX Position: Q2 2026 in Review

Simplex Trading increased its BioNTech (BNTX) stake by 37% in Q2 2026, buying an estimated $491K and bringing the position to 19,254 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2157.

Simplex Trading first reported a position in BNTX in Q4 2020 and has held it in 19 quarters since. The position peaked at $6.87M in Q3 2023. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Simplex Trading held 19,254 shares of BioNTech worth $1.79M as of Q2 2026.
  • Simplex Trading bought 5,221 BioNTech shares in Q2 2026, an estimated $491K.
  • BioNTech made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #2157 holding.
  • Simplex Trading first reported a position in BioNTech in Q4 2020 and has held it in 19 quarters since.
  • Simplex Trading's BioNTech position peaked at $6.87M in Q3 2023.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.